Last reviewed · How we verify
Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer
Current therapies for Metastatic Pancreatic Cancer provide very limited benefit to the patient. The anti-cancer properties of Antineoplaston therapy suggest that it may prove beneficial in the treatment of Metastatic Pancreatic Cancer. PURPOSE: This study is being performed to determine the effects (good and bad) that Antineoplaston therapy has on patients with Metastatic Pancreatic Cancer.
Details
| Lead sponsor | Burzynski Research Institute |
|---|---|
| Phase | PHASE2 |
| Status | TERMINATED |
| Enrolment | 12 |
| Start date | Tue Feb 27 1996 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Fri Dec 31 1999 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Metastatic Prostate Cancer
Interventions
- Antineoplaston therapy (Atengenal + Astugenal)
Countries
United States